A detailed history of Omers Administration Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Omers Administration Corp holds 69,260 shares of ABBV stock, worth $12.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
69,260
Previous 67,860 2.06%
Holding current value
$12.5 Million
Previous $11.6 Million 17.51%
% of portfolio
0.13%
Previous 0.12%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $229,376 - $279,062
1,400 Added 2.06%
69,260 $13.7 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $10.5 Million - $12.3 Million
67,860 New
67,860 $11.6 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $9.95 Million - $12.5 Million
-138,000 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $2.73 Million - $3.29 Million
43,400 Added 45.88%
138,000 $10.4 Million
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $5.79 Million - $7.41 Million
88,200 Added 1378.13%
94,600 $6.97 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $493,696 - $581,056
6,400 New
6,400 $534,000
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $4.66 Million - $5.51 Million
-51,900 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $1.06 Million - $1.42 Million
-11,500 Reduced 18.14%
51,900 $4.91 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $1.67 Million - $1.84 Million
18,700 Added 41.83%
63,400 $6.13 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $3.12 Million - $3.99 Million
44,700
44,700 $3.97 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.